SCHEMBL3977314

SCHEMBL3977314

NNC(=O)c1occc1-c1cccs1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 6/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
POLB P06746 2/20 0.48
KDM4E B2RXH2 9/20 0.44
ALDH1A1 P00352 9/20 0.44
HPGD P15428 6/20 0.40
MAPT P10636 5/20 0.40
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
HSD17B10 Q99714 4/20 0.40
TSHR P16473 2/20 0.40
HDAC1 Q13547 3/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
TDO2 P48775 1/20 0.40
LMNA P02545 2/20 0.39
TP53 P04637 1/20 0.39
HDAC3 O15379 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6668179 0.83 ALDH1A1 (0.50) GAAMEN1KMT2APOLBKDM4E
SCHEMBL25251714 0.81 GPR35 (0.42) GAAMEN1KMT2AKDM4EALDH1A1
SCHEMBL3976773 0.75 ALDH1A1 (0.55) GAAKMT2APOLBKDM4EALDH1A1
SCHEMBL4285451 0.74 MAPT (0.43) GAAMEN1KMT2AKDM4EALDH1A1
SCHEMBL3974414 0.73 GAA (0.35) GAAMEN1KMT2APOLBKDM4E
SCHEMBL28522655 0.73 KDM4E (0.53) GAAMEN1KMT2AKDM4EALDH1A1
SCHEMBL27555736 0.72 MAPT (0.35) GAAMEN1KMT2APOLBKDM4E
SCHEMBL3977123 0.72 MAPT (0.39) GAAMEN1KMT2AKDM4EALDH1A1
SCHEMBL3976975 0.72 KDM4E (0.49) POLBKDM4EALDH1A1HPGDMAPT
SCHEMBL3974408 0.71 GCGR (0.38) MEN1KMT2AKDM4EMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 GAA 1023/4885MEN1 1481/4885KMT2A 3459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.